When semaglutide side effects start — and what to expect

What the STEP 1 trial data tells us about early side effects

The STEP 1 trial (1,961 adults, 68 weeks, semaglutide 2.4mg against placebo, published in the New England Journal of Medicine) gives the clearest picture of when and how side effects unfold in practice. Gastrointestinal events were the dominant safety signal. They clustered heavily in the first four to eight weeks of treatment, corresponding with the lowest doses on the titration ladder, not the highest. That runs counter to what many people expect: it is not the 2.4mg maintenance dose that causes the roughest patch for most people; it is the body's initial encounter with the medicine.

Nausea was the most frequently reported symptom, affecting a meaningful proportion of participants in the active arm. Vomiting, diarrhoea and constipation followed in frequency. The important qualifier from the trial data is that most events were rated mild to moderate in severity, and the majority resolved without stopping treatment. Discontinuation rates due to gastrointestinal side effects were higher in the semaglutide group than placebo but remained a minority of participants overall.

The practical implication is that the first four weeks are often the most unsettled. Smaller, lower-fat meals, staying well hydrated, and eating slowly can all reduce the sharpness of nausea, standard advice your prescriber will go through with you before you begin.

How side effects behave at each dose increase

Semaglutide for weight management follows a step-up schedule: 0.25mg, then 0.5mg, 1.0mg, 1.7mg, and 2.4mg, with roughly four weeks at each level before moving up. Most people find that any side effects they experience follow the same rhythm as their first dose: symptoms arrive in the day or two after each upward step, peak over three to five days, then ease back.

This means the timeline is not a single event but a series of smaller adjustments. If your first dose is unremarkable, a later step-up can still produce nausea for a few days. The reverse is also true: people who feel rough in week one frequently report that subsequent increases are easier to tolerate once their system has adapted to the mechanism of the medicine. There is real individual variation here, and that variation is not predictable from any single factor.

Our clinical team's page on Wegovy side effects covers the full list and how they compare across doses. If you want to understand how the timing compares between the injection and the newer oral option, the Wegovy overview sets out both formats side by side. For anyone weighing up the cost of treatment alongside these considerations, Wegovy pricing explains what private treatment includes.

Side effects that need prompt medical attention

Most people navigate semaglutide's side effects without needing urgent help. But some symptoms should not be managed at home. The MHRA issued a Drug Safety Update in January 2026 drawing clinicians' attention to acute pancreatitis as a known, uncommon but serious risk associated with GLP-1 medicines: severe stomach pain that radiates through to the back, persisting rather than coming and going, with or without vomiting. If that describes what you're experiencing, seek urgent medical assessment rather than waiting for it to pass.

Other symptoms that warrant prompt contact with a doctor or 111: signs of a serious allergic reaction (swelling of the face, throat or tongue; difficulty breathing), symptoms of gallbladder problems (sharp upper-right abdominal pain, fever, jaundice), and signs of dehydration from persistent vomiting or diarrhoea, dizziness, very dark urine, or reduced urination. The MHRA Drug Safety Update index is publicly accessible if you want to read the January 2026 communication in full.

A note on timing: if you start treatment just before a bank holiday, or your dose increase falls on a Friday, make sure you know in advance who to contact over a weekend, our aftercare team is available seven days a week, and the NHS 111 service is always there for anything that feels urgent. Side effects do not respect convenient scheduling.

For a broader look at cardiovascular and other serious safety signals that have been studied in clinical trials, our page on semaglutide and the heart covers the evidence. You can also explore when semaglutide side effects tend to be at their worst for a fuller picture of the overall arc.

What it means to start semaglutide with clinical oversight

The graduated dose structure exists precisely because the side-effect profile was well characterised in trials before the medicine reached patients. A prescriber who knows your medical history can anticipate which symptoms you're more likely to encounter and factor that into the titration plan. That is different from starting a medicine and figuring it out alone.

At nume, every prescription is written by a GPhC-registered Independent Prescriber, not generated by an algorithm. Your consultation is reviewed the same day. If questions come up after your pen arrives (about timing, a symptom you weren't expecting, or whether to pause a dose step) our prescribers are reachable seven days a week. That kind of access matters most in week one and at each step-up, which is exactly when side effects are likeliest to surface.

Semaglutide is a prescription-only medicine under UK law; whether it's the right choice given your health profile is a clinical decision. The question of who gets side effects and how severely is something our team works through with every patient. If you have further questions before you're ready to start, the FAQs cover the most common ones, or you can contact the team directly.